The Cytokinetics Board of Directors contributes know-how, wisdom, supervision and oversight to our business and drug discovery and development activities. The Board members bring decades of pertinent expertise and proficiency as industry executives, investors and academics to bear on key business and research and Development strategies and company implementation.
Members
Robert I. Blum
Cytokinetics, Inc.
Steve Dow
Sevin Rosen Funds
Denise M. Gilbert, Ph.D.
Industry Consultant
A. Grant Heidrich, III
Partner Emeritus, Mayfield Fund
Charles Homcy, M.D.
Portola Pharmaceuticals, Inc.
|
Mark McDade (Lead Outside Director)
Former CEO of PDL BioPharma, Inc.
James H. Sabry, M.D., Ph.D. (Chairman)
Cytokinetics, Inc.
Michael Schmertzler
Aries Advisors, LLC
James Spudich, Ph.D.
Stanford School of Medicine |
